About
Clene Inc. (NASDAQ:CLNN) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 12 2026
Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
Feb 24 2026
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
Jan 16 2026
Clene to Present at the Emerging Growth Conference
Jan 12 2026
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
Jan 9 2026
Clene Announces Registered Direct Offering of Over $28 Million
Financials
Revenue
$200 K
Market Cap
$67.84 M
EPS
-2.65
Translate